HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
Authors:
- Andrew N. BillinABAndrew N. Billin
- Samuel E. HoneycuttSHSamuel E. Honeycutt
- Alan V. McDougalAMAlan V. McDougal
- Jaclyn P. KerrJKJaclyn P. Kerr
- Zhe ChenZCZhe Chen
- Johannes M. FreudenbergJFJohannes M. Freudenberg
- Deepak K. RajpalDRDeepak K. Rajpal
- Guizhen LuoGLGuizhen Luo
- Henning Fritz KramerHKHenning Fritz Kramer
- Robert S. GeskeRGRobert S. Geske
- Frank FangFFFrank Fang
- Bert YaoBYBert Yao
Open Access
- 13 November 2018
- journal article
- research article
- Published by Springer Nature in Skeletal Muscle
- Vol. 8 (1) , 1-14
Abstract
In muscular dystrophy and old age, skeletal muscle repair is compromised leading to fibrosis and fatty tissue accumulation. Therefore, therapies that protect skeletal muscle or enhance repair would be valuable medical treatments. Hypoxia-inducible factors (HIFs) regulate gene transcription under conditions of low oxygen, and HIF target genes EPO and VEGF have been associated with muscle protection and repair. We tested the importance of HIF activation following skeletal muscle injury, in both a murine model and human volunteers, using prolyl hydroxylase inhibitors that stabilize and activate HIF. Using a mouse eccentric limb injury model, we characterized the protective effects of prolyl hydroxylase inhibitor, GSK1120360A. We then extended these studies to examine the impact of EPO modulation and infiltrating immune cell populations on muscle protection. Finally, we extended this study with an experimental medicine approach using eccentric arm exercise in untrained volunteers to measure the muscle-protective effects of a clinical prolyl hydroxylase inhibitor, daprodustat. GSK1120360A dramatically prevented functional deficits and histological damage, while accelerating recovery after eccentric limb injury in mice. Surprisingly, this effect was independent of EPO, but required myeloid HIF1α-mediated iNOS activity. Treatment of healthy human volunteers with high-dose daprodustat reduced accumulation of circulating damage markers following eccentric arm exercise, although we did not observe any diminution of functional deficits with compound treatment. The results of these experiments highlight a novel skeletal muscle protective effect of prolyl hydroxylase inhibition via HIF-mediated expression of iNOS in macrophages. Partial recapitulation of these findings in healthy volunteers suggests elements of consistent pharmacology compared to responses in mice although there are clear differences between these two systems.Keywords
This publication has 46 references indexed in Scilit:
- Requirement of Inducible Nitric Oxide Synthase for Skeletal Muscle Regeneration after Acute DamageThe Journal of Immunology, 2013
- Hypoxia-mediated regulation of macrophage functions in pathophysiologyInternational Immunology, 2012
- An in vivo rodent model of contraction-induced injury in the quadriceps muscleInjury, 2012
- Nitric Oxide Sustains Long-Term Skeletal Muscle Regeneration by Regulating Fate of Satellite Cells Via Signaling Pathways Requiring Vangl2 and Cyclic GMPStem Cells, 2012
- Aberrant repair and fibrosis development in skeletal muscleSkeletal Muscle, 2011
- Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockadeAmerican Journal of Physiology-Renal Physiology, 2010
- Regulatory interactions between muscle and the immune system during muscle regenerationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and ProgressionPLOS ONE, 2007
- Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivoThe Journal of Physiology, 2006
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004